K-Dur Doesn't Apply To Authorized Generic Deals, Judge Says
A New Jersey judge dismissed a putative class action against GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. on Thursday, ruling that the Third Circuit's recent decision subjecting so-called pay-for-delay pharmaceutical patent...To view the full article, register now.
Already a subscriber? Click here to view full article